V L Pulito
Overview
Explore the profile of V L Pulito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Q, Charych E, Pulito V, Lee J, Graziane N, Crozier R, et al.
Mol Psychiatry
. 2010 Sep;
16(10):1006-23.
PMID: 20838393
Disrupted in schizophrenia 1 (DISC1), a genetic risk factor for multiple serious psychiatric diseases including schizophrenia, bipolar disorder and autism, is a key regulator of multiple neuronal functions linked to...
2.
Pulito V, Li X, Varga S, Mulcahy L, Clark K, Halbert S, et al.
J Pharmacol Exp Ther
. 2000 Jun;
294(1):224-9.
PMID: 10871316
The development of alpha(1a)-adrenergic receptor (AR) subtype-selective antagonists is likely to result in uroselective agents that effectively treat benign prostatic hyperplasia (BPH) symptoms without causing undesirable side effects that may...
3.
Xu D, Alegre M, Varga S, Rothermel A, Collins A, Pulito V, et al.
Cell Immunol
. 2000 Mar;
200(1):16-26.
PMID: 10716879
Orthoclone OKT 3 (mOKT3) is a highly effective agent for the reversal of steroid-resistant renal allograft rejection. However, its wider use has been limited by the development of a human...
4.
Pulito V, Roberts V, Adair J, Rothermel A, Collins A, Varga S, et al.
J Immunol
. 1996 Apr;
156(8):2840-50.
PMID: 8609403
OKT4A, a murine mAb that recognizes an epitope on the CD4 receptor, is a potent immunosuppressive agent in vitro and in a variety of nonhuman primate models of graft rejection...
5.
Adair J, Athwal D, Bodmer M, Bright S, Collins A, Pulito V, et al.
Hum Antibodies Hybridomas
. 1994 Jan;
5(1-2):41-7.
PMID: 7858182
OKT3 is a murine monoclonal antibody which recognizes an epitope on the epsilon-subunit within the human CD3 complex. OKT3 possesses potent immunosuppressive properties in vivo and has been proven effective...
6.
Alegre M, Collins A, Pulito V, Brosius R, Olson W, Zivin R, et al.
J Immunol
. 1992 Jun;
148(11):3461-8.
PMID: 1534096
The binding specificity of the murine OKT3 has been transferred into a human antibody framework to reduce its immunogenicity. This "humanized" anti-CD3 mAb (gOKT3-5) was previously shown to retain, in...
7.
Pulito V, Miller D, Sassa S, Yamane T
J Biol Chem
. 1983 Dec;
258(24):14756-8.
PMID: 6317670
A variety of chemical agents that are known to induce erythrodifferentiation in the Friend virus-induced murine erythroleukemia (MEL) cell have been suggested to mediate DNA cleavage in cultured cells prior...
8.
Pulito V, Miller D, Sassa S, Yamane T
Proc Natl Acad Sci U S A
. 1983 Oct;
80(19):5912-5.
PMID: 6310603
The idea of the correlation between DNA damage caused by dimethyl sulfoxide (Me2SO) and the induction of erythrodifferentiation in murine erythroleukemia (MEL) cells needs reevaluation as a result of the...